SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parenteral Drugs India informs about outcome of board meeting

30 Dec 2015 Evaluate

Parenteral Drugs India has informed that the Board of Directors of the Company at its meeting held on December 30, 2015, has considered and approved the disinvestment of equity shares held by the Company in its non-operational Subsidiary Companies i.e. Parentech Healthcare and Parenteral Surgicals as the same are loss making companies, and accorded its in-principle approval to declare the non-working Subsidiaries of the company i.e. Abhay Drugs Limited, Anjaney Pharmaceuticals Limited, Parenteral Biotech and Parenteral Impex as Defunct Company as there is no business in these Subsidiary companies and other items as per agenda of the meeting.

The above information is a part of company’s filings submitted to BSE.

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×